ARCHIVES

Analysis Shows No Mortality Benefit From Regular PSA Screening

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

ACCC Established FCCC Special Interest Group

April 11, 1986

National Organ Site Programs Successful, But Reappraisal Will Continue: Upton

June 23, 1978

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

No Diet, Nutrition, Chemoprevention Concepts Due For DRCCA Board In October, But Maybe In January

July 29, 1983